Target intelligence / Profile preview

CCR4-NOT transcription complex subunit 8 (CNOT8)

Target
CNOT8
Molecular classification
Enzyme (poly(A)-specific 3'-5' exoribonuclease/deadenylase), Component of multisubunit complex (CCR4-NOT complex), Other (deadenylase complex subunit)
01

Overview

CCR4-NOT transcription complex subunit 8 (CNOT8) is an enzymatic component of the multi-subunit CCR4-NOT complex, serving as a poly(A)-specific 3'-5' exoribonuclease (deadenylase)[1][2][6]. CNOT8 regulates mRNA turnover by shortening poly(A) tails, facilitating mRNA decay, and thus modulating the abundance, stability, and translational efficiency of key transcripts[1][5][3]. It is crucial for post-transcriptional gene silencing, including miRNA-mediated gene regulation, and is essential for processes such as cell proliferation, embryonic development, and pluripotency state transitions[2][3][6][7]. CNOT8 shows partly redundant functions with its paralog CNOT7, but is indispensable for viability in both mouse and human cells, underscoring its core role in gene expression control[7][1]. Disruption of CNOT8 destabilizes cellular transcriptomes, can cause embryonic lethality in mice, and is associated with biological phenomena including cancer progression and developmental disorders[3][7][2]. CNOT8 is not currently considered a direct therapeutic target and is not associated with known small-molecule drugs or clinically used inhibitors, but its central regulatory function may make it of interest for future disease-modifying interventions targeting abnormal mRNA turnover.

Other names
Caf1bHCAF1CALIFPOP2CAF1hCAF1CAF1-like proteinCAF2CCR4-associated factor 8CALIFpPGK promoter directed over production
02

Biological functions

mRNA deadenylation (removal of poly(A) tails from mRNA)Post-transcriptional gene regulation (including miRNA-mediated silencing)Regulation of mRNA stability and degradationPositive and negative regulation of gene expressionCell population proliferation controlRegulation of cell pluripotency transition
03

Disease associations

Cancer (impact on cell proliferation and tumor progression)Developmental disease (mouse knockout: embryonic lethality)Other (potential links to metabolic disease via mRNA stability control)
04

Safety considerations

Essential for cell viability (loss leads to cell death in primary cells)Embryonic lethality in knockout miceBroad impact on mRNA stability may affect off-target gene silencing or global gene expression[7][3]

Beyond the preview

Go deeper on CCR4-NOT transcription complex subunit 8 (CNOT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCR4-NOT transcription complex subunit 8 (CNOT8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call